Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Merck & Co., Inc.
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.

Number of employees : 74 000 people.
Sales per Business
20192020Delta
Pharmaceutical41 751.0089.6%43 021.0089.6% +3.04%
Animal Health4 393.009.4%4 703.009.8% +7.06%
Other521.001.1%247.000.5% -52.59%
Other Segment175.000.4%23.000% -86.86%
USD in Million
Sales per region
20192020Delta
United States20 325.0043.6%21 027.0043.8% +3.45%
Europe, Middle East and Africa12 707.0027.3%13 600.0028.3% +7.03%
China3 207.006.9%3 624.007.5% +13%
Japan3 583.007.7%3 376.007% -5.78%
Asia Pacific2 943.006.3%2 864.006% -2.68%
Latin America2 469.005.3%2 274.004.7% -7.9%
Other1 606.003.4%1 229.002.6% -23.47%
USD in Million
Managers
Name Title Age Since
Robert Davis President, Chief Executive Officer & Director 53 2021
Caroline Litchfield Chief Financial Officer & Executive Vice President - 2021
Sandy Tremps Vice President-R&D IT CIO - 2016
Dave Williams Chief Information & Digital Officer - -
Thomas Henry Glocer Independent Director 60 2007
Leslie Brun Lead Independent Director 67 2014
Patricia Russo Independent Director 67 1995
Peter C. Wendell Independent Director 69 2003
Pamela J. Craig Independent Director 63 2015
Paul B. Rothman, Dr. Independent Director 62 2015
Members of the board
Name Title Age Since
Kenneth Frazier Executive Chairman 65 2021
Thomas Henry Glocer Independent Director 60 2007
Leslie Brun Lead Independent Director 67 2014
Patricia Russo Independent Director 67 1995
Peter C. Wendell Independent Director 69 2003
Robert Davis President, Chief Executive Officer & Director 53 2021
Pamela J. Craig Independent Director 63 2015
Paul B. Rothman, Dr. Independent Director 62 2015
Inge Thulin Independent Director 66 2018
Mary Ellen Coe Independent Director 52 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,577,858,139 2,530,289,139 70.7% 1,045,799,775 29.2% 70.7%
Shareholders
NameEquities%
The Vanguard Group, Inc. 226,691,766 8.95%
BlackRock Fund Advisors 79,346,436 3.13%
SSgA Funds Management, Inc. 53,667,054 2.12%
Geode Capital Management LLC 41,303,871 1.63%
Wellington Management Co. LLP 39,553,593 1.56%
Norges Bank Investment Management 27,515,487 1.09%
Charles Schwab Investment Management, Inc. 26,215,908 1.04%
Capital Research & Management Co. (Global Investors) 23,613,195 0.93%
Massachusetts Financial Services Co. 21,646,815 0.85%
Janus Capital Management LLC 19,065,814 0.75%
Holdings
NameEquities%Valuation
NGM BIOPHARMACEUTICALS, INC. (NGM) 12,955,016 16.8% 255,472,916 USD
SUTRO BIOPHARMA, INC. (STRO) 2,723,509 5.91% 50,630,032 USD
KALVISTA PHARMACEUTICALS, INC. (KALV) 1,070,589 4.38% 25,651,312 USD
1,193,046 3.71% 19,434,719 USD
LAVA THERAPEUTICS B.V. (LVTX) 1,082,679 4.27% 11,779,548 USD
4D PHARMA PLC (DDDD) 8,315,023 4.61% 11,234,095 USD
YUMANITY THERAPEUTICS, INC. (YMTX) 526,999 5.17% 6,139,538 USD
Markets and indexes
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Company contact information
Merck & Co., Inc.
2000 Road Galloping Hill
PO Box 100
NJ 07033 Kenilworth, New Jersey

Phone : +1 908 423 1000
Fax : +1 908 735 1253
web site : http://www.merck.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Merck & Co., Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
MERCK & CO., INC.-4.24%198 336
JOHNSON & JOHNSON9.40%453 418
ROCHE HOLDING AG12.49%332 374
PFIZER, INC.18.04%243 220
ELI LILLY AND COMPANY46.00%224 084
NOVARTIS AG0.39%223 750
ABBVIE INC.10.64%209 386
NOVO NORDISK A/S34.72%209 246
ASTRAZENECA PLC12.86%177 726
BRISTOL-MYERS SQUIBB COMPANY10.80%153 463
AMGEN INC.6.23%140 335
SANOFI11.30%129 607
GLAXOSMITHKLINE PLC4.44%97 346
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-25.48%61 235
BAYER AG4.91%58 597
JIANGSU HENGRUI MEDICINE CO., LTD.-40.67%54 870
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.03%52 741
DAIICHI SANKYO COMPANY, LIMITED-37.04%38 723
ASTELLAS PHARMA INC.19.64%32 066
EISAI CO., LTD.26.28%24 103